Eversept Partners’s Zimmer Biomet ZBH Stock Holding History

Eversept Partners’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-14,420	Closed	-$1.69M	–	62
2017 Q4	$1.69M	Buy	+14,420	New	+$1.63M	0.97%	24

Other funds holding ZBH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Eversept Partners's ZBH Position: Q1 2018 in Review

Eversept Partners sold out of Zimmer Biomet (ZBH) in Q1 2018, closing a stake of 14,420 shares — an estimated $1.69M sold.

Eversept Partners first reported a position in ZBH in Q4 2017 and held it in 1 quarter. The position peaked at $1.69M in Q4 2017. 875 funds tracked by Wall St. Rank hold ZBH as of Q1 2018.

Eversept Partners reported no remaining Zimmer Biomet position as of Q1 2018 after selling out during the quarter.
Eversept Partners sold 14,420 Zimmer Biomet shares in Q1 2018, an estimated $1.69M.
Eversept Partners first reported a position in Zimmer Biomet in Q4 2017 and held it in 1 quarter.
Eversept Partners's Zimmer Biomet position peaked at $1.69M in Q4 2017.
875 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2018.

Based on Eversept Partners's 13F filing for Q1 2018, filed 14 May 2018.